A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 17, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MITI SEC filings page.
Mitesco Inc (MITI) reported $39K in revenue for fiscal year 2025, down 11.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Reported profitability sits beside a balance sheet dominated by liabilities, while revenue remains too small to fund the operating structure.
In FY2025, reported net income of$499K exceeded revenue of$38.7K by more than twelve times, so the result is not readily interpretable as conventional, sales-driven operating earnings. Between FY2024 and FY2025, revenue declined from$43.7K to$38.7K while R&D rose from zero to$82K , indicating a shift toward development spending even as reported earnings turned positive.
The latest balance sheet carries liabilities of
The latest reported operating cash flow was
Financial Health Signals
Mitesco Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Mitesco Inc passes 3 of 5 computable financial strength tests (4 of the nine could not be computed from available data). All 1 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
Key Financial Metrics
Earnings & Revenue
Mitesco Inc generated $20K in revenue in Q2 2026. This represents an increase of 7.0% from the same quarter a year earlier.
Not reported for Q2 2026.
Not reported for Q2 2026.
Cash & Balance Sheet
Mitesco Inc held $8K in cash against $0 in long-term debt as of Q2 2026, with $22.4M of liabilities due within a year.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Not reported for Q2 2026.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not reported for Q2 2026.
Not reported for Q2 2026.
Capital Allocation
Mitesco Inc invested $33K in research and development in Q2 2026. This represents an increase of 56.9% from the same quarter a year earlier. Against the prior quarter it is down 68.0%.
Not reported for Q2 2026.
Not reported for Q2 2026.
MITI Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'26S-1/A | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'25S-1/A | Q4'24S-1/A | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20K+7.0% | $0-100.0% | $0 | $3K-87.2% | $19K+211.7% | $17K | N/A | $24K |
| R&D Expenses | $33K+56.9% | $104K+1860.1% | $54K | $1K | $21K | $5K | N/A | $0 |
| SG&A Expenses | $446K+29.4% | N/A | N/A | N/A | $345K | $279K+105.7% | N/A | $231K+451.5% |
| Operating Income | -$459K-30.5% | N/A | N/A | N/A | -$352K | -$267K-97.1% | N/A | -$216K-416.4% |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$216K-416.4% |
| Income Tax | N/A | $0 | N/A | N/A | N/A | $0 | N/A | N/A |
| Net Income | N/A | N/A | N/A | N/A | -$87K | N/A | N/A | N/A |
| EPS (Basic) | -$0.05-400.0% | -$0.05-114.3% | $0.03+105.6% | -$0.27-184.4% | -$0.01+93.3% | $0.35+418.2% | -$0.54-133.8% | $0.32+166.7% |
| EPS (Diluted) | -$0.05 | -$0.05 | $0.06 | -$0.27-193.1% | -$0.01+93.3% | -$0.08+27.3% | -$0.53+91.2% | $0.29+160.4% |
| Diluted Shares (Avg) | 20M | 17M | N/A | 12M+73.2% | 15M+150.4% | 12M+114.2% | N/A | 7M+31.0% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Interest Expense.
MITI Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'26S-1/A | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'25S-1/A | Q4'24S-1/A | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $102K-40.5% | $31K-83.4% | $132K-30.4% | $166K+170.2% | $171K+269.5% | $190K+239.9% | $190K+6589.3% | $61K+133.1% |
| Current Assets | $102K+165.2% | $31K-33.8% | $132K+247.0% | $40K-34.3% | $38K-17.1% | $48K-14.8% | $38K+1241.4% | $61K+133.1% |
| Cash & Equivalents | $8K+193.1% | $2K+711.1% | $101K+2864.6% | $321-99.0% | $3K-93.2% | $189-99.5% | $3K+19.9% | $32K+29.1% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | $38K+12.9% | $28K-36.8% | $28K-7.1% | $36K | $33K | $44K | $30K | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $24.4M+9.8% | $23.9M+7.1% | $23.6M-11.3% | $24.0M+98.6% | $22.2M+46.5% | $22.3M+51.7% | $26.6M+88.2% | $12.1M-31.1% |
| Current Liabilities | $22.4M+40.8% | $19.5M+29.8% | $19.4M+5.2% | $17.6M+45.8% | $15.9M+4.7% | $15.0M+2.0% | $18.4M+30.5% | $12.1M-31.1% |
| Non-Current Liabilities | $2.0M-68.1% | $4.4M-39.5% | $4.2M-48.5% | $6.4M | $6.3M | $7.3M | $8.2M | $0 |
| Long-Term Debt | $0 | N/A | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Equity | -$24.3M-10.2% | -$23.9M-7.9% | -$23.5M+11.1% | -$23.8M-98.2% | -$22.1M-45.8% | -$22.2M-51.0% | -$26.4M-86.9% | -$12.0M+31.4% |
| Retained Earnings | -$65.1M-7.6% | -$64.1M-6.2% | -$63.4M+0.8% | -$63.7M-5.6% | -$60.5M+3.1% | -$60.4M+2.6% | -$63.9M-2.9% | -$60.3M+4.9% |
Not reported in any period shown, so not listed: Inventory, Goodwill.
MITI Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'26S-1/A | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'25S-1/A | Q4'24S-1/A | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$275K-203.8% | N/A | -$393K-242.5% | -$121K+20.3% | -$91K+3.5% | -$97K+36.9% | -$115K | -$152K |
| Depreciation & Amortization | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0 |
| Stock-Based Compensation | N/A | $52K+725.0% | N/A | N/A | N/A | $6K | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | -$5K | N/A |
| Financing Cash Flow | $337K+261.5% | $120K+27.8% | $493K+440.7% | $119K-17.3% | $93K-0.1% | $94K-51.0% | $91K+1457.6% | $143K+3062.0% |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
MITI Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'26S-1/A | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'25S-1/A | Q4'24S-1/A | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2294.4% | N/A | N/A | N/A | -1881.0% | -1570.5% | N/A | -920.2% |
| Net Margin | N/A | N/A | N/A | N/A | -467.3% | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | -51.2% | N/A | N/A | N/A |
| Current Ratio | 0.000.0x | 0.000.0x | 0.010.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.010.0x |
| Asset Turnover | 0.20+0.1x | 0.00-0.1x | 0.00 | 0.02-0.4x | 0.110.0x | 0.09+0.1x | N/A | 0.38+0.4x |
Not reported in any period shown, so not listed: Gross Margin, Return on Equity, Debt-to-Equity, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Note: Shareholder equity is negative (-$23.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Mitesco Inc MITI | FY2025 | $39K | $499K | N/A | $3.6M | — |
| Careview Comm CRVW | FY2025 | $9.0M | -$3.2M | -35.5% | $23.4M | — |
| LOGICMARK INC LGMK | FY2025 | $11.4M | -$7.5M | -65.4% | $6.6M | — |
Where Mitesco Inc Ranks
Frequently Asked Questions
What is Mitesco Inc's annual revenue?
Mitesco Inc (MITI) reported $39K in total revenue for fiscal year 2025. This represents a -11.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Mitesco Inc's revenue growing?
Mitesco Inc (MITI) revenue declined by 11.4% year-over-year, from $44K to $39K in fiscal year 2025.
Is Mitesco Inc profitable?
Yes, Mitesco Inc (MITI) reported a net income of $499K in fiscal year 2025.
How much debt does Mitesco Inc have?
As of fiscal year 2025, Mitesco Inc (MITI) had $101K in cash and equivalents against $0 in long-term debt.
What are Mitesco Inc's total assets?
Mitesco Inc (MITI) had $132K in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Mitesco Inc spend on research and development?
Mitesco Inc (MITI) invested $82K in research and development during fiscal year 2025.
What is Mitesco Inc's current ratio?
Mitesco Inc (MITI) had a current ratio of 0.01 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Mitesco Inc's return on assets (ROA)?
Mitesco Inc (MITI) had a return on assets of 377.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Mitesco Inc's P/E ratio?
Mitesco Inc (MITI) trades at 7.3x earnings, its market capitalization divided by net income of $499K net income, FY2025. The market capitalization is $3.6M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Mitesco Inc's price-to-sales ratio?
Mitesco Inc (MITI) trades at 158x sales, its market capitalization divided by revenue of $23K revenue, trailing 12 months to June 30, 2026. The market capitalization is $3.6M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Why is Mitesco Inc's debt-to-equity ratio negative or not reported?
Mitesco Inc (MITI) has negative shareholder equity of -$23.5M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Mitesco Inc's Piotroski F-Score?
Mitesco Inc (MITI) has a Piotroski F-Score of 3 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.